2Appel JM, Sogaard P, Mortensen CE, et al . Tissue- Doppler assessment of cardiac left ventricular function during short - term adjuvant epirubicin therapy for breast cancer[ J]. Journal of the American Society of Echocardioaphy ,2011, 24 (2) :200-206.
3Correale M, Totaro A, Ieva R, et al. Tissue Doppler imaging in coronary artery diseases and heart failure [ J ] . Curt Cardiol Rex,, 2012, 8( 1 ),43-53.
5Park CS, Kim YK, Song HC, et al. Effect of preload on left atr - ial function:evaluated by tissue Doppler and strain imaging [ J ] . Eur Heart J Cardiovasc Imaging, 2012, 13 (11) :938-947.
6Rickard J, Kumbhani DJ, Baranowski B, et al. Usefulness of cardiac resynchronization therapy in patients with Adriamycin - induced cardiomyopathy[ J]. Am J Cardiol 2010,105 (4) :522- 526.
8kapusta L, Thijssen JM, Groot- loonen J, et al. Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines [ J ] . Ultrasound Med Biol,2000,26 ( 7 ) : 1099-1108.
8Lopez M. Dexrazoxane. Current status and prospectives of cardiotoxicity of chemotherapy[ J]. Clin Ter, 1999,150 ( 1 ) :37-49.
9Johnson GL, Moffett CB, Geil JD, et al. Late echocardiographic findings following childhood chemotherapy with normal serial cardiac monitoring [ J ]. J Pediatr Heamatol Oncol, 1996,18 : 72.
10Rhoden W, Hasleten P, Brooks H. Anthracyclines and heart [ J]. Eur Heart J, 1993,70 : 499.
